The renoprotective effects of sodium-glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: A systematic review and meta-analysis

Wang, C; Zhou, Y; Kong, ZL; Wang, X; Lv, WS; Geng, Z; Wang, YG

Wang, YG (reprint author), Qingdao Univ, Affiliated Hosp, Dept Endocrinol, Qingdao 266003, Peoples R China.

DIABETES OBESITY & METABOLISM, 2019; 21 (4): 1018

Abstract

Aims We undertook a systematic review and meta-analysis to assess the efficacy and safety of sodium-glucose cotransporter 2 inhibitors (SGLT2is) conce......

Full Text Link